-
OPPI members reiterate commitment to address coronavirus situation in India
expresspharma
March 23, 2020
"OPPI and its member companies reassure availability of adequate supplies of medicines for those in need of them," the industry body said in a statement.
-
U.S. Approves Abbott Labs Coronavirus Test For Hospital Use
forbes
March 20, 2020
Abbott Laboratories won U.S. approval for its molecular test for the Coronavirus strain COVID-19, which will be used by hospitals and academic medical centers to speed diagnostic capabilities ...
-
Study finds Covid-19 coronavirus of natural origin
pharmaceutical-technology
March 20, 2020
A new study led by Scripps Research Institute has shown that the novel coronavirus, SARS-CoV-2, which causes Covid-19, is of natural origin and not engineered in a laboratory.
-
Whole genomes of coronavirus from UK patients sequenced by Sheffield scientists
expresspharma
March 20, 2020
The work forms part of a worldwide emergency response to the outbreak, helping coordinate agile responses to new infectious diseases as they spread and mutate in local populations.
-
CII proposed action points for strengthening the healthcare and pharma sectors amidst ongoing Coronavirus crisis
expresspharma
March 20, 2020
The Confederation of Indian Industry (CII) has brought out action points for strengthening the healthcare and pharmaceutical sectors for combating the Coronavirus crisis.
-
The COVID-19 coronavirus epidemic has a natural origin
worldpharmanews
March 19, 2020
The novel SARS-CoV-2 coronavirus that emerged in the city of Wuhan, China, last year and has since caused a large scale COVID-19 epidemic ...
-
Emergent, Vaxart Ink Coronavirus Pact
contractpharma
March 19, 2020
Sign development and manufacturing agreement for experimental oral vaccine candidate.
-
Moleculin, UTMB partner to study WP1122 for coronavirus
pharmaceutical-technology
March 19, 2020
Moleculin Biotech has partnered with the University of Texas Medical Branch at Galveston (UTMB) to test its molecular inhibitors, including WP1122, to treat different viruses ...
-
Study finds novel coronavirus can remain stable for days
pharmaceutical-technology
March 19, 2020
A study led by the US National Institutes of Health found that the novel coronavirus that causes Covid-19 can be viable in air for several hours and on surfaces for days.
-
Moderna Leads Coronavirus Vaccine Charge
contractpharma
March 19, 2020
First participant dosed in NIH-led Phase 1 study of mRNA vaccine against novel coronavirus.